Annual Shareholders Equity
$1.22 M
-$6.17 M-83.44%
June 1, 2024
Summary
- As of February 7, 2025, GENE annual stockholders equity is $1.22 million, with the most recent change of -$6.17 million (-83.44%) on June 1, 2024.
- During the last 3 years, GENE annual shareholders equity has fallen by -$14.96 million (-92.44%).
- GENE annual shareholders equity is now -94.44% below its all-time high of $22.00 million, reached on June 30, 2007.
Performance
GENE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.22 M
-$2.06 M-62.68%
June 1, 2024
Summary
- As of February 7, 2025, GENE quarterly stockholders equity is $1.22 million, with the most recent change of -$2.06 million (-62.68%) on June 1, 2024.
- Over the past year, GENE quarterly shareholders equity has dropped by -$6.17 million (-83.44%).
- GENE quarterly shareholders equity is now -95.21% below its all-time high of $25.54 million, reached on December 31, 2005.
Performance
GENE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
GENE Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -83.4% | -83.4% |
3 y3 years | -92.4% | -83.4% |
5 y5 years | -1.4% | -83.4% |
GENE Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -92.4% | at low | -91.3% | at low |
5 y | 5-year | -92.4% | at low | -92.4% | at low |
alltime | all time | -94.4% | at low | -95.2% | +394.1% |
Genetic Technologies Limited Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | $1.22 M(-83.4%) | $1.22 M(-62.7%) |
Dec 2023 | - | $3.28 M(-55.6%) |
Jun 2023 | $7.39 M(-34.6%) | $7.39 M(-1.5%) |
Dec 2022 | - | $7.50 M(-33.6%) |
Jun 2022 | $11.30 M(-30.1%) | $11.30 M(-19.8%) |
Dec 2021 | - | $14.10 M(-12.8%) |
Jun 2021 | $16.18 M(+68.3%) | $16.18 M(+20.4%) |
Dec 2020 | - | $13.44 M(+39.8%) |
Jun 2020 | $9.61 M(+675.1%) | $9.61 M(+379.8%) |
Dec 2019 | - | $2.00 M(+61.5%) |
Jun 2019 | $1.24 M(-64.2%) | $1.24 M(-41.7%) |
Dec 2018 | - | $2.13 M(-38.6%) |
Jun 2018 | $3.46 M(-57.4%) | $3.46 M(-39.5%) |
Dec 2017 | - | $5.72 M(-29.6%) |
Jun 2017 | $8.13 M(-8.4%) | $8.13 M(-23.6%) |
Dec 2016 | - | $10.64 M(+19.9%) |
Jun 2016 | $8.87 M(-39.0%) | $8.87 M(-23.7%) |
Dec 2015 | - | $11.63 M(-20.0%) |
Jun 2015 | $14.54 M(+745.2%) | $14.54 M(+5773.1%) |
Dec 2014 | - | $247.60 K(-85.6%) |
Jun 2014 | $1.72 M(-67.1%) | $1.72 M(-73.5%) |
Dec 2013 | - | $6.49 M(+24.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2013 | $5.23 M(-63.4%) | $5.23 M(-53.4%) |
Dec 2012 | - | $11.22 M(-21.5%) |
Jun 2012 | $14.29 M(+102.3%) | $14.29 M(-1.7%) |
Dec 2011 | - | $14.54 M(+105.8%) |
Jun 2011 | $7.07 M(+51.9%) | $7.07 M(-29.4%) |
Dec 2010 | - | $10.01 M(+115.2%) |
Jun 2010 | $4.65 M(-58.6%) | $4.65 M(-46.6%) |
Dec 2009 | - | $8.72 M(-22.5%) |
Jun 2009 | $11.25 M(-43.1%) | $11.25 M(-13.4%) |
Dec 2008 | - | $12.98 M(-34.3%) |
Jun 2008 | $19.77 M(-10.1%) | $19.77 M(-11.9%) |
Dec 2007 | - | $22.45 M(+2.0%) |
Jun 2007 | $22.00 M(+63.9%) | $22.00 M(+11.7%) |
Dec 2006 | - | $19.70 M(+46.7%) |
Jun 2006 | $13.43 M(-22.0%) | $13.43 M(-47.4%) |
Dec 2005 | - | $25.54 M(+48.4%) |
Jun 2005 | $17.21 M(+45.7%) | $17.21 M(+29.7%) |
Dec 2004 | - | $13.27 M |
Jun 2004 | $11.81 M(+181.3%) | - |
Jun 2003 | $4.20 M(+1.9%) | - |
Jun 2002 | $4.12 M(-29.2%) | - |
Jun 2001 | $5.82 M(+28.8%) | - |
Jun 2000 | $4.52 M | - |
FAQ
- What is Genetic Technologies Limited annual stockholders equity?
- What is the all time high annual shareholders equity for Genetic Technologies Limited?
- What is Genetic Technologies Limited annual shareholders equity year-on-year change?
- What is Genetic Technologies Limited quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Genetic Technologies Limited?
- What is Genetic Technologies Limited quarterly shareholders equity year-on-year change?
What is Genetic Technologies Limited annual stockholders equity?
The current annual shareholders equity of GENE is $1.22 M
What is the all time high annual shareholders equity for Genetic Technologies Limited?
Genetic Technologies Limited all-time high annual stockholders equity is $22.00 M
What is Genetic Technologies Limited annual shareholders equity year-on-year change?
Over the past year, GENE annual stockholders equity has changed by -$6.17 M (-83.44%)
What is Genetic Technologies Limited quarterly stockholders equity?
The current quarterly shareholders equity of GENE is $1.22 M
What is the all time high quarterly shareholders equity for Genetic Technologies Limited?
Genetic Technologies Limited all-time high quarterly stockholders equity is $25.54 M
What is Genetic Technologies Limited quarterly shareholders equity year-on-year change?
Over the past year, GENE quarterly stockholders equity has changed by -$6.17 M (-83.44%)